January 15, 2020
Health Canada has issued a No Objection Letter in response to IntelGenx’s amended application for its ongoing trial in patients...
January 13, 2020
IntelGenx confirmed that its cannabis-infused oral film, VersaFilm, is on track to be released commercially in Q1 2020.
October 9, 2019
The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.
September 4, 2019
One pharmaceutical company is giving consumers the chance to experience the effects of cannabis in a new form: oral strips.
May 8, 2019
IntelGenx (TSXV:IGX, OTCQX:IGXT) has announced it has entered into a partnership with Aquestive Therapeutics (NASDAQ:AQST) to co-develop and commercialize Tadalafil...
May 1, 2019
IntelGenx announced the issuance of a patent from the United States Patent and Trademark Office covering the design and manufacturing of topical...
January 30, 2019
IntelGenx (TSXV:IGX,OTCQX:IGXT) a leading oral drug delivery company, today announced that the U.S. Food and Drug Administration has performed a...